Analysis
New frontiers in implantable neuromodulation therapies
Sergio and Alejandra explore emerging implantable neuromodulation therapies that are opening new possibilities in the rapidly evolving field.
Tag: Drug Delivery
News
Re-Vana Therapeutics enters collaboration with Cambridge Design Partnership
Re-Vana Therapeutics enters collaboration with Cambridge Design Partnership on development of novel delivery system for OcuLief®, an in-situ forming implant for the sustained release of biologic ophthalmic formulations.
Analysis
Trends in respiratory therapies: why pMDIs hang in the balance of new technology
Steve Augustyn, our Deputy Head of Drug Delivery reflects on key themes for respiratory therapy
Analysis
Care tech: exploring the latest trends in dementia care
Karla Sanchez explores the rapidly evolving field of dementia care, examining both the current landscape and emerging technologies that empower patients to stay independent for longer.
Analysis
Neurodegenerative conditions: turning a corner to better treatment?
Pace is accelerating for tackling neurodegenerative diseases. In this article, Biomedical Engineers Alejandra and Karla focus on two areas of progress: how treatments have moved on and hope for the future.
Analysis
Could oligonucleotide manufacturing advances redefine therapy?
Therapeutic oligonucleotides are a promising therapy for future applications. Here, biomedical engineers, Alejandra and Carla, discuss the challenges that need to be addressed to unlock large-scale oligonucleotide manufacturing.
Whitepaper
Developing future drug delivery systems
This paper explores the future of drug delivery systems, specifically at-home self-injection, and the way in which drugs will be packaged in the future to enhance patient experience and ensure successful clinical outcomes.
Analysis
Key trends in respiratory drug delivery
Fresh from 'Drug Delivery to the Lungs' conference in Edinburgh, Mark Allen shares his insights on the major themes from the event and a trend set to reshape the future of respiratory drug delivery.
Analysis
Reducing the carbon footprint and plastic waste of LFTs: Evidence-based opportunities
With urgent and important demand for LFTs, jeopardizing performance, ease-of-use, supply chain availability, and low cost isn’t an option – but sustainability strategies are evolving in response to consumer expectations.
Analysis
Mastering fluid flow to enhance user experience
Ice cream and blood are two things you probably don’t want to think about simultaneously, but how a substance flows is a vitally important consideration for many products.
Analysis
Prepare the way: Pilot manufacture for drug delivery devices
Senior Consultant Jon Powell shares some of the obstacles encountered conducting pilot builds in-house to help our clients bring devices to market – and gives four pointers for ideal pilot manufacturing for clinical trials.
Webinar
Realizing the potential of FemTech
Join Martha Hodgson and Jessica Platt and explore how the power of inclusive, experience-centered design and smart application of technology has accelerated the rise of FemTech.